Healios K.K. (TYO:4593)
363.00
-18.00 (-4.72%)
At close: Feb 6, 2026
Healios K.K. Employees
Healios K.K. had 65 employees as of December 31, 2024. The number of employees increased by 1 or 1.56% compared to the previous year.
Employees
65
Change (1Y)
1
Growth (1Y)
1.56%
Revenue / Employee
1.49M JPY
Profits / Employee
-59.85M JPY
Market Cap
42.01B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 65 | 1 | 1.56% |
| Dec 31, 2023 | 64 | -7 | -9.86% |
| Dec 31, 2022 | 71 | -45 | -38.79% |
| Dec 31, 2021 | 116 | 2 | 1.75% |
| Dec 31, 2020 | 114 | 76 | 200.00% |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Takara Bio | 1,779 |
| GNI Group | 867 |
| Nxera Pharma | 384 |
| Japan Tissue Engineering | 204 |
| RaQualia Pharma | 64 |
| Cuorips | 56 |
| AnGes | 55 |
| StemRIM | 45 |